2021-04-08T07:04:52Z
2021-04-08T07:04:52Z
2018-03-28
2021-04-08T07:04:52Z
INTRODUCTION: Apolipoprotein E (APOE)-ε4 is the major genetic risk factor for Alzheimer's disease. However, the dose-dependent impact of this allele on brain morphology of healthy individuals remains unclear. METHODS: We analyzed gray matter volumes (GMvs) in a sample of 533 healthy middle-aged individuals with a substantial representation of ε4-carriers (207 heterozygotes and 65 homozygotes). RESULTS: We found APOE-ε4 additive GMv reductions in the right hippocampus, caudate, precentral gyrus, and cerebellar crus. In these regions, the APOE genotype interacted with age, with homozygotes displaying lower GMv after the fifth decade of life. APOE-ε4 was also associated to greater GMv in the right thalamus, left occipital gyrus, and right frontal cortex. DISCUSSION: Our data indicate that APOE-ε4 exerts additive effects on GMv in regions relevant for Alzheimer's disease pathophysiology already in healthy individuals. These findings elucidate the mechanisms underlying the increased Alzheimer's disease risk in ε4-carriers, suggesting a dose-dependent disease vulnerability on the brain structure level.
Article
Versió publicada
Anglès
Malaltia d'Alzheimer; Factors de risc en les malalties; Envelliment; Proteïnes; Genètica; Alzheimer's disease; Risk factors in diseases; Aging; Proteins; Genetics
Elsevier Masson
Reproducció del document publicat a: https://doi.org/10.1016/j.jalz.2018.01.016
Alzheimer's & Dementia, 2018, vol. 14, num. 7, p. 902-912
https://doi.org/10.1016/j.jalz.2018.01.016
cc-by-nc-nd (c) Cacciaglia, Raffaele et al., 2018
http://creativecommons.org/licenses/by-nc-nd/3.0/es